Abstract
Objective: To evaluate two poorly explored neurotrophins (NT), NT-3 and NT-4/5, in bipolar disorder (BD).
Methods: Forty patients with type I BD (18 in remission and 22 in mania) and 25 healthy controls matched for age, gender, and educational attainment were enrolled in this study. All subjects were assessed by the Mini-International Neuropsychiatric Interview; the Young Mania Rating Scale and the Hamilton Depression Rating Scale were used to evaluate severity of symptoms in BD patients. Plasma levels of NT-3 and NT-4/5 were measured by enzyme-linked immunosorbent assay (ELISA).
Results: BD patients in mania presented decreased NT-4/5 plasma levels in comparison with controls (p, 0.05). There were no significant differences in NT-3 plasma levels between BD patients and controls.
Conclusion: These findings corroborate the view that neurotrophin dysfunction is associated with mood states in patients with BD.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 340-343 |
| Number of pages | 4 |
| Journal | Revista Brasileira de Psiquiatria |
| Volume | 36 |
| Issue number | 4 |
| DOIs | |
| State | Published - Oct 1 2014 |
| Externally published | Yes |
Keywords
- Biomarker
- Bipolar disorder
- Depression
- Mania
- Neurotrophin
ASJC Scopus subject areas
- Psychiatry and Mental health